The Validity of MRI in Evaluation of Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Abstract

Background: Physical Examination (PE) and breast MRI are two of the current methods which have usually used in diagnosis of primary breast cancer. Their accuracy in detection of: either complete response or presence of residual tumor, however, has not yet been established in patients who have been received Neoadjuvant Chemotherapy (NAC). The purpose of this study was to evaluate the diagnostic accuracy of breast MRI in assessment of residual neoplastic tissue after NAC in patients with Locally Advanced Breast Cancer (LABC).